• CA4P Is Well Tolerated, May Benefit Platinum-resistant Ovarian Cancer Patients, Trial Shows
  • Tesaro’s Ovarian Cancer Therapy Zejula Moves One Step Closer to EU Approval
  • Abdominal Fat Increases Risk of Postmenopausal Women Developing Some Cancers, Study Suggests
  • Mobile App Helps Ovarian Cancer Patients Monitor Tumor Markers
  • Rubraca as Maintenance Therapy Seen to Aid Survival Without Disease Progression in Range of Patients
  • Tumor DNA in Blood Used to Detect Many Early-stage Ovarian and Other Cancers in Study
  • Phase 1 Clinical Trial Is Assessing Cantrixil in Ovarian Cancer Patients Who Are Resistant to Chemo
  • Lynparza Maintenance Reduces Risk of Disease Progression in Advanced Ovarian Cancer Patients, SOLO-2 Trial Shows
  • Celsion to Present New Data from OVATION Trial at Ovarian Cancer Meeting
  • Cancer Research UK Tests Therapy for Advanced Ovarian, Other Cancers in Phase 1 Trial
  • Most Women with History of Ovarian or Breast Cancer Are Not Receiving Recommended Genetic Tests, Study Finds
  • Biotech Completes Dose Escalation Part of Phase 1 Study of COTI-2 in Gynecological Cancers